Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
Source
New patent expiration for Merck Sharp drug PREVYMIS Read Post »
This chart shows the drugs with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Cyprus? Read Post »
Annual Drug Patent Expirations for ZILBRYSQ Zilbrysq is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…
Source
Annual Drug Patent Expirations for PURIFIED+CORTROPHIN+GEL Purified Cortrophin Gel is a drug marketed by Ani Pharms and is included in one NDA. It is available from one supplier. The generic…
Source
New patent for Ani Pharms drug PURIFIED CORTROPHIN GEL Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are five patents…
Source
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. It is available from one supplier. There are fourteen…
Source
Annual Drug Patent Expirations for VIZAMYL Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There are three patents…
Source
New patent expiration for Ge Healthcare drug VIZAMYL Read Post »
This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Philippines? Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are five patents…
Source
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Source
Drug Patent Expirations for the Week of May 19, 2024 Read Post »
Get new actionable insights and updates from BiotechBlog
